Total Visits

Views
Initial results of a clinical trial evaluating a full-length pegylated recombinant factor viii with extended half-life for the perioperative control of hemostasis in hemophilia A45

Select a period of time:

Views

Views
January 20250
February 20253
March 202516
April 20252
May 20251
June 20251
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
United States3
United Kingdom3
Spain1
Mexico1
 

Top cities views

Views
Council Bluffs1
La Piedad1